Carbon dioxide induction of panic anxiety in schizophrenia with auditory hallucinations

Psychiatry Research

Volumn 189, Issue 1, 2011, Pages 38-42

  Savitz, Adam Jonathan ^a   Kahn, Tara Ann ^a   McGovern, Kelly Elizabeth ^a   Kahn, Jeffrey Paul ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Auditory hallucinations; Co morbidity; Panic challenge; Panic disorder; Schizophrenia; Voices

Indexed keywords

ANTIPANIC AGENT; ARIPIPRAZOLE; ATENOLOL; CARBON DIOXIDE; CITALOPRAM; CLONAZEPAM; CLONIDINE; CLOZAPINE; ENALAPRIL; ESCITALOPRAM; LITHIUM DERIVATIVE; METOPROLOL; OLANZAPINE; PALIPERIDONE; PAROXETINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROIC ACID; ZIPRASIDONE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CARBON DIOXIDE BREATHING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; PANIC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; STRUCTURED INTERVIEW;

ADULT; ANTICONVULSANTS; CARBON DIOXIDE; CLONAZEPAM; DOUBLE-BLIND METHOD; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 80051679796     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.06.008     Document Type: Article

References (35)

1. Argyle N., Deltito J., Allerup P., Maier W., Albus M., Nutzinger D., Rasmussen S., Ayuso J.L., Bech P. The Panic-Associated Symptom Scale: measuring the severity of panic disorder. Acta Psychiatrica Scandinavica 1991, 83:20-26.
2. Bailey J.E., Nutt D.J. GABA-A receptors and the response to CO2 inhalation - a translational trans-species model of anxiety?. Pharmacology Biochemistry and Behavior 2008, 90:51-57.
3. Braga R.J., Petrides G., Figueira I. Anxiety disorders in schizophrenia. Comprehensive Psychiatry 2004, 45:460-468.
4. Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin 2009, 35:383-402.
5. Cassano G.B., Pini S., Saettoni M., Rucci P., Dell'Oss L. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. Journal of Clinical Psychiatry 1998, 59:60-68.
6. Chen C.Y., Liu C.Y., Yang Y.Y. Correlation of panic attacks and hostility in chronic schizophrenia. Psychiatry and Clinical Neurosciences 2001, 55:383-387.
7. Ciapparelli A., Paggini R., Marazziti D., Carmassi C., Bianchi M., Taponecco C., Consoli G., Lombardi V., Massimetti G., Dell'osso L. Comorbidity with axis I anxiety disorders in remitted psychotic patients 1year after hospitalization. CNS Spectrums 2007, 12:913-919.
8. Craig T., Hwang M.Y., Bromet E.J. Obsessive-compulsive and panic symptoms in patients with first-admission psychosis. American Journal of Psychiatry 2002, 59:592-800.
9. Csernansky J.G., Lombrozo L., Gulevich G.D., Hollister L.E. Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study. Journal of Clinical Psychopharmacology 1984, 4:349-352.
10. Davidson J.R. Use of benzodiazepines in panic disorder. Journal Clinical Psychiatry 1997, 58(Supplement 2):26-28.
11. Freire R.C., Perna G., Nardi A.E. Panic disorder respiratory subtype: psychopathology, laboratory challenge tests, and response to treatment. Harvard Review of Psychiatry 2010, 18:220-228.
12. Gonzalez-Burgos G., Lewis D.A. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophrenia Bulletin 2008, 34:944-961.
13. Goodwin R., Lyons J.S., McNally R.J. Panic attacks in schizophrenia. Schizophrenia Research 2002, 58:213-220.
14. Goodwin R.D., Amador X.F., Malaspina D., Yale S.A., Goetz R.R., Gorman J.M. Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophrenia Research 2003, 61:89-95.
15. Goodwin R.D., Fergusson D.M., Horwood L.J. Panic attacks and psychoticism. American Journal of Psychiatry 2004, 161:88-92.
16. Heun R., Maier W. Relation of schizophrenia and panic disorder: evidence from a controlled family study. American Journal of Medical Genetics 1995, 60:127-132.
17. Hofmann S.G. Relationship between panic and schizophrenia. Depression and Anxiety 1999, 9:101-106.
18. Huppert J.D., Smith T.E. Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms. CNS Spectrums 2005, 10:721-731.
19. Kahn J.P., Puertollano M., Schane M.D., Klein D.F. Schizophrenia, panic anxiety, and alprazolam. American Journal of Psychiatry 1987, 144:527-528.
20. Kahn J.P., Puertollano M.A., Schane M.D., Klein D.F. Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications. American Journal of Psychiatry 1988, 145:742-744.
21. Kahn J.P., Meyers J.R. Treatment of comorbid panic disorder and schizophrenia: evidence for a panic psychosis. Psychiatric Annals 2000, 30:29-33.
22. Kay S.R., Opler L.A., Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Research 1988, 23:99-110.
23. Kovnick J.A., Appelbaum P.S., Hoge S.K., Leadbetter R.A. Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatric Services 2003, 54:1247-1252.
24. Labbate L.A., Young P.C., Arana G.W. Panic disorder in schizophrenia. The Canadian Journal of Psychiatry 1999, 44:488-490.
25. Lysaker P.H., Salyers M.P. Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history. Acta Psychiatrica Scandinavica 2007, 116:290-298.
26. Muller J.E., Koen L., Soraya S., Emsley R.A., Stein D.J. Anxiety disorders and schizophrenia. Current Psychiatry Reports 2004, 6:255-261.
27. Nardi A.E., Valença A.M., Lopes F.L., Nascimento I., Veras A.B., Freire R.C., Mezzasalma M.A., de-Melo-Neto V.L., Zin W.A. Psychopathological profile of 35% CO2 challenge test-induced panic attacks: a comparison with spontaneous panic attacks. Comprehensive Psychiatry 2006, 47:209-214.
28. Perna G., Bertani A., Caldirola D., Di Pasquale D., Migliarese G., Bellodi L. Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. Journal of Clinical Psychopharmacology 2004, 24:277-282.
29. Rassovsky Y., Kushner M.G. Carbon dioxide in the study of panic disorder: issues of definition, methodology, and outcome. Journal of Anxiety Disorders 2003, 17:1-32.
30. Siris S.G. Suicide and schizophrenia. Journal of Psychopharmacology 2001, 15:127-135.
31. Tibbo P., Swainson J., Chue P., LeMelledo J.M. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia. Depression and Anxiety 2003, 17:65-72.
32. Turnbull G., Bebbington P. Anxiety and the schizophrenic process: clinical and epidemiological evidence. Social Psychiatry and Psychiatric Epidemiology 2001, 36:235-243.
33. Ulas H., Alptekin K., Akdede B.B., Tumuklu M., Akvardar Y., Kitis A., Polat S. Panic symptoms in schizophrenia: comorbidity and clinical correlates. Psychiatry and Clinical Neuroscience 2007, 6:678-680.
34. Verburg K., Pols H., de Leeuw M., Griez E. Reliability of the 35% carbon dioxide panic provocation challenge. Psychiatry Research 1998, 78:207-214.
35. Volz A., Khorsand V., Gillies D., Leucht S. Benzodiazepines for schizophrenia. Cochrane Database of Systematic Reviews 2007, 1:CD006391.